FDA Adverse Event Injury Summary report: N

OPTIFLUX 180NRE DIALYZER FINISHED ASSY.

MDR report key: 3190386 · Received June 21, 2013

Report

Report Number
1713747-2013-00201
Event Type
Injury
Date Received
June 21, 2013
Date of Event
March 29, 2013
Report Date
May 29, 2013
Manufacturer
FRESENIUS MEDICAL CARE NORTH AMERICA
Product Code
FJI
PMA / PMN Number
K002761
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT REPORTED REACTIONS SUCH AS HEADACHE, NAUSEA, VOMITING AND A HOLLOW TYPE FEELING IN HIS EARS WITH THE USE OF A FRESENIUS DIALYZER. THE PATIENT WENT THROUGH MULTIPLE TREATMENTS AND DID NOT REPORT THE REACTIONS UNTIL 25 TREATMENTS WERE COMPLETED. TREATMENT SHEETS FOR THE PATIENT'S LAST TREATMENT WITH THE USE OF A FRESENIUS DIALYZER WERE PROVIDED. THE TREATMENT SHEETS INDICATE THAT THE PATIENT HAD NO COMPLAINTS DURING TREATMENT AND COMPLETED TREATMENT WITH NO ISSUES. CURRENTLY, IT IS UNKNOWN IF THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. THE PATIENT WAS REPORTED TO HAVE CHANGED MANUFACTURER OF THE DIALYZER AND IS DOING BETTER WITH LESS HEADACHES. BASED ON THE AVAILABLE INFORMATION, NO DEFINITIVE CONCLUSION CAN BE DRAWN. PLEASE REFERENCE MDR#'S: 1713747-2013-00200 THROUGH 1713747-2013-00224.

Description of Event or Problem · 1

THE PATIENT REPORTED TO HIS CLINIC THAT HE HAD BEEN EXPERIENCING MULTIPLE REACTIONS TO THE FRESENIUS DIALYZER SINCE THE START OF HIS TREATMENT. THE PATIENT'S SYMPTOMS INCLUDED HEADACHES, NAUSEA, VOMITING, AND A HOLLOW FEELING IN THE EARS. THE PATIENT BEGAN TREATMENT ON (B)(6) 2013 AND CONTINUED TREATMENT 3 TIMES PER WEEK UNTIL HIS LAST TREATMENT WITH A FRESENIUS DIALYZER ON (B)(6) 2013. THE PATIENT'S DIALYZER PRESCRIPTION WAS CHANGED TO A NON-FRESENIUS PRODUCT. THE PATIENT IS REPORTED TO BE DOING BETTER AND EXPERIENCING LESS HEADACHES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
283917 OPTIFLUX 180NRE DIALYZER FINISHED ASSY. FJI FRESENIUS MEDICAL CARE NORTH AMERICA

Patients

Seq Age Sex Outcome Treatment
1 43 YR Required Intervention FRESENIUS 2008K2